No Data
Amgen Analyst Ratings
Live Stock: First Week Down, Market Pulls Back a Hair After Records
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $324
Allurion (ALUR.US) stock price surged violently; its new weight loss therapy can maintain muscle mass.
On Thursday, Allurion's stock price soared 80% in after-hours trading, following reports that the company plans to conduct clinical research combining its gastric balloon weight loss product with GLP-1 drugs.
Allurion Stock Soars 70% on Weight-loss Therapy Update
Wall Street Today: S&P 500 Closes at Record, Trump Keeps Appearing on TV
Growth Investor27 : I own a lot & will buy more
DazzlerAus : agree but nothing seems to help
Youngman : I keep hearing nothing but good things about the stock while it goes down lol